日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Influence of body composition on the efficacy of nivolumab plus ipilimumab for metastatic clear cell renal cell carcinoma

体成分对纳武利尤单抗联合伊匹木单抗治疗转移性透明细胞肾细胞癌疗效的影响

Grewal, Kabir; Moura Nascimento Santos, Maria Julia; Chauhan, Pankaj Kumar; Yu, Kai; Tannir, Nizar M; Mukhida, Sagar S; Venkatesh, Neha; Shah, Amishi Y; Zurita, Amado J; Johns, Andrew C; Campbell, Matthew T; Goswami, Sangeeta; Gao, Jianjun; Jonasch, Eric; McQuade, Jennifer L; Alhalabi, Omar; Msaouel, Pavlos; Hahn, Andrew W

Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability

免疫检查点阻断疗法治疗伴有DNA错配修复缺陷或微卫星不稳定性晚期上尿路尿路上皮癌的疗效

Moussa, Mohammad Jad; Andreev-Drakhlin, Alexander Y; Venkatesan, Aradhana M; Matin, Surena F; Xiao, Lianchun; Tidwell, Rebecca S S; Shah, Amishi Y; Adriazola, Ana C; Shaw, Leah; Gao, Jianjun; Lin, John K; Goswami, Sangeeta; Msaouel, Pavlos; Guo, Charles C; Tannir, Nizar M; Siefker-Radtke, Arlene O; Alhalabi, Omar; Campbell, Matthew T

Control arm overperformance in phase 3 oncology clinical trials

对照组在3期肿瘤临床试验中表现优于对照组

Nalin, Ansel P; Msaouel, Pavlos; Grippin, Adam J; Kouzy, Ramez; Abi Jaoude, Joseph; Lin, Timothy A; Miller, Avital M; Meimoun, Noah S; Ludmir, Ethan B; Sherry, Alexander D

Random Assignment, But Without Comparison: A Missed Opportunity

随机分配,但缺乏比较:错失良机

Sherry, Alexander D; Ludmir, Ethan B; Msaouel, Pavlos

Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma

肾细胞癌对免疫检查点抑制剂的异常反应的免疫基因组学决定因素

Jammihal, Tejas; Saliby, Renee Maria; Labaki, Chris; Soulati, Hanna; Gallegos, Juan; Peris, Arnau; McCurry, Dustin; Yu, Chunlei; Shah, Valisha; Poduval, Deepak; El Zarif, Talal; El Ahmar, Nourhan; Laimon, Yasmin Nabil; Eid, Marc; Sheshdeh, Aseman Bagheri; Krajewski, Katherine M; Büttner, Florian A; Schwab, Matthias; Heng, Daniel; Casellas, Rafael C; Rai, Kunal; Zacharias Millward, Niki M; Msaouel, Pavlos; Karam, Jose; Signoretti, Sabina; Van Allen, Eliezer; Choueiri, Toni K; Braun, David A; Shukla, Sachet A

Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis

现代 III 期肿瘤临床试验中总生存期和生活质量优势:一项荟萃流行病学分析

Sherry, Alexander D; Miller, Avital M; Parlapalli, Jnana Preeti; Kupferman, Gabrielle S; Beck, Esther J; McDonald, Jordan; Kouzy, Ramez; Abi Jaoude, Joseph; Lin, Timothy A; Sanford, Nina N; Chino, Fumiko; Gyawali, Bishal; Booth, Christopher; Msaouel, Pavlos; Ludmir, Ethan B

Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial

西曲替尼联合纳武利尤单抗和伊匹木单抗治疗晚期透明细胞肾细胞癌患者:一项 I 期试验

Msaouel, Pavlos; Yu, Kai; Yuan, Ying; Chen, Jianfeng; Yan, Xinmiao; Karki, Menuka; Duan, Fei; Sheth, Rahul A; Rao, Priya; Sircar, Kanishka; Shah, Amishi Y; Zurita, Amado J; Genovese, Giannicola; Li, Min; Yeh, Chih-Chen; Dang, Minghao; Han, Guangchun; Chu, Yanshuo; Hallin, Max; Olson, Peter; Yang, Rui; Slavin, Daniela; Der-Torossian, Hirak; Chin, Curtis D; Tannir, Nizar M; Wang, Linghua; Gao, Jianjun

Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.

纳武利尤单抗联合伊匹木单抗可诱导肾髓质癌超进展:II期试验结果和临床前证据。

Soeung Melinda, Yan Xinmiao, Zanca Ciro, Qian Jing, Karki Menuka, Duan Fei, Khan Hania, Zhang Li, Peng David H, Williams Mariah, He Rong, Chen Ziheng, Perelli Luigi, Chen Jianfeng, Tidwell Rebecca S, Chauhan Pankaj K, Le Courtney N, Lam Truong N A, Bhattacharya Nirjar, Shah Rutvi, Ho I-Lin, Gay Jason P, Carrillo Caroline C, Feng Ningping, Le Kang, Gao Guang, Perry Teresa L, Mseeh Faika, Jiang Yongying, Xu Quanyun A, Zacharias Niki Marie, Sheth Rahul A, Bathala Tharakeswara K, Rao Priya, Daw Najat C, Tripathi Durga N, Walker Cheryl L, Mohammad Mohammad M, Zhang Jianhua, Han Guangchun, Chu Yanshuo, Wang Ruiping, Dang Minghao, Dai Enyu, Peng Fuduan, Liu Yunhe, Jadhav Akshaya, Lang Wenhua, Arrechedera Claudio A, Clemente Leticia Campos, Parra Edwin R, Lu Hsinyi, Haymaker Cara L, Wistuba Ignacio I, Futreal Andrew, Viale Andrea, Soth Michael J, Jones Philip, Marszalek Joseph R, Heffernan Timothy, Draetta Giulio F, Tannir Nizar M, Gao Jianjun, Wang Linghua, Genovese Giannicola, Msaouel Pavlos

Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma

纳武利尤单抗联合伊匹木单抗治疗转移性变异型(非透明细胞)肾细胞癌患者的疗效和安全性

Moussa, Mohammad Jad; Khandelwal, Jaanki; Wilson, Nathaniel R; Malikayil, Kiran L; Surasi, Devaki Shilpa; Bathala, Tharakeswara K; Lin, Yiyun; Rao, Priya; Tamboli, Pheroze; Sircar, Kanishka; Ajufo, Helen; Elsayes, Khaled M; Shah, Amishi; Johns, Andrew C; Goswami, Sangeeta; Hasanov, Elshad; Jonasch, Eric; Msaouel, Pavlos; Campbell, Matthew T; Alhalabi, Omar; Tannir, Nizar M

Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling.

通过整合基因组和转录组分析鉴定肾髓质癌的治疗靶点。

Msaouel Pavlos, Tannir Nizar M, Meric-Bernstam Funda, King Jennifer M, Voss Martin H, Cheng Jessica P, Thomas Susan S, Lim Zita D, Karki Menuka, He Rong, Genovese Giannicola, Sheth Rahul A, Ingram Davis R, Shamsutdinova Diana, Wani Khalida M, Wang Wei-Lien, Lazar Alexander J, Knipper-Davis Dominique, Berlinski Amber, Soares Tayla, Stupichev Danil, Kryukov Kirill, Davitavyan Suren, Novokreshchenova Anna, Lebedev Dmitry, Kurpe Stanislav, Kravets Andrey, Belousov Dmitrii, Hensley Michael, Bagaev Alexander, Paradiso Francesca, Kushnarev Vladimir